Q2 FY2026 · ended Jun 30, 2026 · Revenue $32.91M, +34.4% YoY · Filed Aug 10, 2026
Quanterix Corporation (QTRX) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $32.9 million and a net loss of $48.9 million. Free cash flow was -$5.2 million. As of Jun 30, 2026 it held $93.5 million in cash and investments and $33.4 million in total debt.
Revenue
$32.91M
+34.4% vs year-ago quarter
Net income
$-48.93M
-63.0% vs year-ago quarter
Operating cash flow
$-5.12M
+9.5% vs year-ago quarter
Free cash flow
$-5.21M
+18.9% vs year-ago quarter
EPS
$-1.04
-35.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
47.29M
+1.8% vs year-ago quarter
Net cash
$60.14M
Q2 FY2026
Operating margin
-99.6%
TTM
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- QTRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Billerica, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1503274
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $32.9M | $36.4M | $43.9M | $40.2M | $24.5M |
| Operating income | -$49.4M | -$41.4M | -$24.8M | -$37.3M | -$37.1M |
| Net income | -$48.9M | -$17.5M | -$23.1M | -$33.5M | -$30.0M |
| Diluted EPS | -$1.04 | -$0.37 | -$0.49 | -$0.73 | -$0.77 |
| Operating cash flow | -$5.1M | -$18.1M | -$16.4M | -$41.2M | -$5.7M |
| Free cash flow | -$5.2M | -$18.2M | -$16.5M | -$41.9M | -$6.4M |
| Total assets | $319.6M | $366.7M | $418.8M | $444.1M | $375.6M |
| Total liabilities | $82.4M | $84.5M | $123.0M | $129.6M | $83.2M |
| Stockholders' equity | $237.2M | $282.1M | $295.7M | $314.5M | $292.5M |
| Cash and investments | $93.5M | $99.3M | $118.2M | $134.8M | $261.2M |
| Total debt | $33.4M | $35.3M | $37.2M | $40.1M | $35.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 9, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Officer or director change
|
May 26, 2026 | May 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 12, 2026 | May 11, 2026 |
All 1000 Quanterix Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.